leadf
logo-loader
viewProactive Group

Life Sciences company Quanterix launches IPO at US$14 to US$16 per share

Quanterix digitises biomarker analysis with the aim of advancing the science of precision health. Its technology is aimed at enabling earlier detection of disease, better prognosis and enhanced treatment methods to improve the quality and longevity of life

test tubes
Its technology is currently being used for research applications in oncology, neurology, cardiology, inflammation and infectious disease.

Quanterix Corp (NASDAQ:OTRX) has launched its Initial Public Offering (IPO) on Monday, offering a total of 3.34 million shares priced at US$14 to US$16 per share.

At the midpoint price range, the company will raise a total of US$50.1mln.

Company digitises biomarker analysis

J.P. Morgan, Leerink Partners and Cowen are joint bookrunners on the deal with BTIG and Evercore ISI acting as co-managers. The life sciences company is set to list on Nasdaq.

The Massachusetts-based company will use the proceeds from the IPO to expand its commercial operations, improve and update its Simoa technology, as well as support a 2018 product launch.

Part of the monies will also go towards moving to a larger corporate headquarters, seek regulatory approval to develop certain instruments, to pursue acquisitions and for general corporate purposes.

Quanterix digitises biomarker analysis with the aim of advancing the science of precision health. Its technology is aimed at enabling earlier detection of disease, better prognosis and enhanced treatment methods to improve the quality and longevity of life.

Its technology is currently being used for research applications in oncology, neurology, cardiology, inflammation and infectious disease.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Anglo Pacific Group announce 'largest ever acquisition' to seize upon...

Anglo Pacific Group PLC's (LON:APF, TSE:APY) Chief Financial Officer Kevin Flynn talks to Proactive London about their deal to acquire a 70% net interest in a stream on cobalt production from the Voisey's Bay mine in Canada. Flynn says this is the 'largest ever acquisition' for the firm and...

1 hour, 28 minutes ago

2 min read